Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Clin Microbiol ; 57(2)2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30463895

RESUMEN

Group B Streptococcus (GBS) is the leading cause of neonatal sepsis and meningitis in developed countries. Recommendations for antepartum GBS detection include enriched culture with several options for identifying GBS, some of which are time-consuming. To reduce the time for identification and determination of the maternal GBS colonization status, rapid nucleic acid amplification technologies have been developed and commercialized. For rapid detection of GBS, a three-site clinical study was conducted to evaluate the NeuMoDx GBS assay, a real-time PCR test performed for vaginal/rectal swab specimens in Lim broth enrichment culture on the NeuMoDx 288 molecular system (NeuMoDx system); these data were used to a support 510(k) submission. A total of 1,250 eligible remnant samples were prospectively enrolled and tested during the study. The results of the PCR assay were compared to the results of the Centers for Disease Control and Prevention (CDC)-recommended enriched-culture method, which served as the gold standard reference method for the study. The NeuMoDx GBS assay results yielded a sensitivity of 96.9% (95% confidence interval [CI] = 94.1 to 98.4), specificity of 96.0% (95% CI = 94.6 to 97.1), and a total agreement with the reference method of 96.2% (95% CI = 93.8 to 98.3). NeuMoDx GBS assay results were also compared to results obtained using the BD MAX GBS assay on the BD MAX system. The two systems demonstrated a total percent agreement of 98.0% (95% CI = 95.5 to 100.0). The performance of the NeuMoDx GBS assay implemented on the NeuMoDx system compared favorably to the CDC enriched-culture method and to the BD MAX GBS assay.


Asunto(s)
Portador Sano/diagnóstico , Técnicas de Diagnóstico Molecular/métodos , Complicaciones Infecciosas del Embarazo/diagnóstico , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Infecciones Estreptocócicas/diagnóstico , Streptococcus agalactiae/aislamiento & purificación , Adulto , Femenino , Humanos , Lactante , Recién Nacido , Embarazo , Estudios Prospectivos , Recto/microbiología , Sensibilidad y Especificidad , Streptococcus agalactiae/clasificación , Streptococcus agalactiae/genética , Vagina/microbiología
2.
Meat Sci ; 126: 11-17, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27984700

RESUMEN

Functional magnetic resonance imaging (fMRI) has been used to unveil how some foods and basic rewards are processed in the human brain. This study evaluated how resting state functional connectivity in regions of the human brain changed after differing qualities of beef steaks were consumed. Functional images of participants (n=8) were collected after eating high or low quality beef steaks on separate days, after consumption a sensory ballot was administered to evaluate consumers' perceptions of tenderness, juiciness, flavor, and overall liking. Imaging data showed that high quality steak samples resulted in greater functional connectivity to the striatum, medial orbitofrontal cortex, and insular cortex at various stages after consumption (P≤0.05). Furthermore, high quality steaks elicited higher sensory ballot scores for each palatability trait (P≤0.01). Together, these results suggest that resting state fMRI may be a useful tool for evaluating the neural process that follows positive sensory experiences such as the enjoyment of high quality beef steaks.


Asunto(s)
Imagen por Resonancia Magnética , Carne Roja/análisis , Gusto , Adulto , Animales , Bovinos , Comportamiento del Consumidor , Culinaria , Femenino , Calidad de los Alimentos , Humanos , Procesamiento de Imagen Asistido por Computador , Masculino , Adulto Joven
3.
Ann Oncol ; 23(11): 2820-2827, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22571859

RESUMEN

BACKGROUND: Neoadjuvant therapy has been investigated for localized and locally advanced pancreatic ductal adenocarcinoma (PDAC) but no standard of care exists. Combination cetuximab/gemcitabine/radiotherapy demonstrates encouraging preclinical activity in PDAC. We investigated cetuximab with twice-weekly gemcitabine and intensity-modulated radiotherapy (IMRT) as neoadjuvant therapy in patients with localized or locally advanced PDAC. EXPERIMENTAL DESIGN: Treatment consisted of cetuximab load at 400 mg/m(2) followed by cetuximab 250 mg/m(2) weekly and gemcitabine 50 mg/m(2) twice-weekly given concurrently with IMRT to 54 Gy. Following therapy, patients were considered for resection. RESULTS: Thirty-seven patients were enrolled with 33 assessable for response. Ten patients (30%) manifested partial response and 20 (61%) manifested stable disease by RECIST. Twenty-five patients (76%) underwent resection, including 18/23 previously borderline and 3/6 previously unresectable tumors. Twenty-three (92%) of these had negative surgical margins. Pathology revealed that 24% of resected tumors had grade III/IV tumor kill, including two pathological complete responses (8%). Median survival was 24.3 months in resected patients. Outcome did not vary by epidermal growth factor receptor status. CONCLUSIONS: Neoadjuvant therapy with cetuximab/gemcitabine/IMRT is tolerable and active in PDAC. Margin-negative resection rates are high and some locally advanced tumors can be downstaged to allow for complete resection with encouraging survival. Pathological complete responses can occur. This combination warrants further investigation.


Asunto(s)
Adenocarcinoma/terapia , Anticuerpos Monoclonales/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Desoxicitidina/análogos & derivados , Neoplasias Pancreáticas/terapia , Radioterapia de Intensidad Modulada , Adulto , Anciano , Anciano de 80 o más Años , Anticuerpos Monoclonales/efectos adversos , Anticuerpos Monoclonales Humanizados , Antimetabolitos Antineoplásicos/efectos adversos , Antimetabolitos Antineoplásicos/uso terapéutico , Antineoplásicos/efectos adversos , Antineoplásicos/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Cetuximab , Desoxicitidina/administración & dosificación , Desoxicitidina/efectos adversos , Receptores ErbB/biosíntesis , Femenino , Humanos , Masculino , Persona de Mediana Edad , Terapia Neoadyuvante/efectos adversos , Radioterapia de Intensidad Modulada/efectos adversos , Resultado del Tratamiento , Gemcitabina
4.
Semin Oncol ; 26(5 Suppl 16): 27-31; discussion 41-2, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10585006

RESUMEN

Docetaxel and gemcitabine have been shown to be active as single agents in a variety of solid tumors. These two agents have been studied in combination with several different treatment schedules. Two phase I studies used a novel 2-week administration schedule that involved a 1-hour infusion of 35 mg/m2 to 65 mg/m2 docetaxel and gemcitabine administered as either a 30-minute infusion (2,000 to 4,000 mg/m2) or a 10 mg/m2/min infusion (1,000 to 1,200 mg/m2 total dose). Another novel phase I study evaluated the effect of drug sequence on toxicities. Patients received 30 to 40 mg/m2 docetaxel and 800 to 1,250 mg/m2 gemcitabine on days 1 and 8 every 21 days. Two phase I studies of a monthly docetaxel regimen have been conducted. Patients received 800 mg/m2 gemcitabine on days 1, 8, and 15 and 100 mg/m2 docetaxel on day 1 of a 28-day cycle. Finally, in a phase II study, patients received 900 mg/m2 gemcitabine on days 1 and 8 and 100 mg/m2 docetaxel on day 8, with granulocyte colony-stimulating factor administered on days 9 through 15. In these studies, antitumor responses were observed in lung cancer as well as a number of other histologies. Neutropenia was the most frequent dose-limiting toxicity and no difference in clinical toxicity was observed with either sequence of administration. The emerging evidence suggests, therefore, that the combination of gemcitabine and docetaxel is active in a variety of solid tumors and is well tolerated.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Neoplasias Pulmonares/tratamiento farmacológico , Taxoides , Ensayos Clínicos Fase I como Asunto , Ensayos Clínicos Fase II como Asunto , Desoxicitidina/administración & dosificación , Desoxicitidina/análogos & derivados , Docetaxel , Humanos , Paclitaxel/administración & dosificación , Paclitaxel/análogos & derivados , Gemcitabina
5.
Cancer Genet Cytogenet ; 96(2): 118-22, 1997 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-9216718

RESUMEN

We observed a translocation (2;22)(p23;q11.2) in the bone marrow cells of a patient with multiple subcutaneous nodules. Tumor histology and immunohistochemical staining demonstrated a malignant lymphoma, diffuse large cell type, displaying a CD30 negative B cell immunophenotype. To our knowledge, this is the first report of this specific translocation in lymphoma, which may join the site of the anaplastic lymphoma kinase (ALK) gene at 2p23 to the region of the immunoglobulin lambda light chain gene at 22q11.2. The ALK gene was initially identified through its involvement in the t(2;5)(p23;q35) found most commonly in anaplastic large cell lymphoma. This observation in a CD30 negative large cell lymphoma of B cell lineage further extends the relationship of anaplastic large cell morphology, ALK activation, lymphoid lineage, and expression of the CD30 antigen.


Asunto(s)
Aberraciones Cromosómicas/genética , Cromosomas Humanos Par 22 , Cromosomas Humanos Par 2 , Linfoma de Células B Grandes Difuso/genética , Quinasa de Linfoma Anaplásico , Linfocitos B , Bandeo Cromosómico , Trastornos de los Cromosomas , Humanos , Hibridación Fluorescente in Situ , Antígeno Ki-1/análisis , Masculino , Persona de Mediana Edad , Proteínas Tirosina Quinasas/genética , Proteínas Tirosina Quinasas Receptoras , Translocación Genética
6.
Pediatr Res ; 34(2): 167-72, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8233720

RESUMEN

The effects of passive respiratory syncytial virus (RSV) immune serum given as preinoculation prophylaxis, postinoculation prophylaxis, and as therapy on d 5 after inoculation were evaluated in an illness model of RSV infection in BALB/c mice. Pre- and postinoculation prophylaxis reduced RSV replication in lung after primary RSV infection and prevented illness. Day 5 treatment did not affect peak titer of RSV in lung but resulted in more rapid recovery from illness than seen in untreated mice. Prophylaxis prevented antibody responses and lymphocytic infiltrates in lung after primary RSV infection. Treatment caused diminished antibody and pathologic responses. Prophylaxis increased susceptibility to reinfection, although illness after rechallenge was mild. Mice treated therapeutically were less susceptible to reinfection than mice treated prophylactically, but they also experienced mild illness after rechallenge. Passive antibody prophylaxis and treatment of RSV infection are promising approaches to attenuating lower respiratory tract illness from primary RSV infection. The ability to measure illness endpoints and pathology make the BALB/c mouse model of RSV infection a useful system for the preclinical evaluation of immunoprophylactic and immunotherapeutic modalities.


Asunto(s)
Inmunización Pasiva , Infecciones por Virus Sincitial Respiratorio/prevención & control , Infecciones por Virus Sincitial Respiratorio/terapia , Animales , Anticuerpos Antivirales/administración & dosificación , Anticuerpos Antivirales/uso terapéutico , Modelos Animales de Enfermedad , Estudios de Evaluación como Asunto , Femenino , Técnicas In Vitro , Ratones , Ratones Endogámicos BALB C , Pruebas de Neutralización , Infecciones por Virus Sincitial Respiratorio/patología , Virus Sincitiales Respiratorios/inmunología , Virus Sincitiales Respiratorios/fisiología , Replicación Viral
7.
Am J Pathol ; 142(6): 1841-7, 1993 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8506952

RESUMEN

Analysis of immunoglobulin gene rearrangements by Southern blotting is a sensitive and specific method for detecting B cell malignancies but requires a relatively large amount of intact DNA. It cannot be utilized in many cases where only a small amount of tissue is available or where the tissue has been fixed. This report demonstrates that polymerase chain reaction (PCR) amplification in conjunction with single-strand conformational polymorphism (SSCP) analysis can be utilized to detect clonal immunoglobulin heavy chain (IgH) gene rearrangements. IgH gene rearrangements from a series of frozen or formalin-fixed B cell malignancies were PCR-amplified using oligonucleotide primers, based upon consensus sequences in the IgH variable and joining regions. Analysis of the single-stranded PCR products on nondenaturing polyacrylamide gels revealed discrete SSCPs corresponding to the malignant B cells. These SSCPs were detectable when the malignant cells represented as few as 0.2% of the total mononuclear cells in peripheral blood. PCR amplification in conjunction with SSCP analysis thus provides a sensitive and specific method to detect clonal IgH rearrangements from minute amounts of fresh, frozen, or fixed tissue.


Asunto(s)
ADN de Cadena Simple/genética , Reordenamiento Génico/genética , Cadenas Pesadas de Inmunoglobulina/genética , Secuencia de Bases , Southern Blotting , Clonación Molecular , ADN de Neoplasias/genética , Electroforesis en Gel de Poliacrilamida , Humanos , Leucemia Linfocítica Crónica de Células B/genética , Leucemia Linfocítica Crónica de Células B/patología , Linfoma de Células B/metabolismo , Linfoma de Células B/patología , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Polimorfismo Genético
8.
N Engl J Med ; 326(17): 1115-22, 1992 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-1532439

RESUMEN

BACKGROUND: Lymphomatoid papulosis is a benign cutaneous eruption that in 10 to 20 percent of patients is associated with the development of lymphoma. The atypical cells of lymphomatoid papulosis histologically resemble the malignant cells of cutaneous T-cell lymphoma or the Reed-Sternberg cells of Hodgkin's disease. We studied a patient in whom lymphomatoid papulosis developed in 1971, Hodgkin's disease in 1975, and cutaneous T-cell lymphoma in 1985, to determine whether these diseases are clonally related. METHODS: The T-cell-receptor alpha-chain gene was cloned and sequenced from a cell line derived from the advanced-stage cutaneous T-cell lymphoma, and the polymerase chain reaction was used to search for this rearrangement of the alpha-chain gene in tissues obtained earlier that were affected by Hodgkin's disease or lymphomatoid papulosis. RESULTS: The tumor-specific rearrangement of the alpha-chain gene was detected in the patient's earlier tissues affected by lymphomatoid papulosis and Hodgkin's disease, but not in control tissue, including uninvolved tissues from the staging laparotomy for Hodgkin's disease. Cytogenetic studies revealed a translocation, t(8;9)(p22;p24), in cutaneous T-cell lymphoma lines and in a dermatopathic lymph node removed two years before the clinical onset of the cutaneous T-cell lymphoma. Immunohistochemical findings were consistent with an activated T-cell phenotype for the atypical cells of lymphomatoid papulosis, the Reed-Sternberg cells of Hodgkin's disease, and the malignant cells of the T-cell lymphoma. CONCLUSIONS: Lymphomatoid papulosis, Hodgkin's disease, and cutaneous T-cell lymphoma can be derived from a single T-cell clone. A t(8;9) genetic translocation may be involved in the pathogenesis of lymphomatoid papulosis or its progression to malignant disease.


Asunto(s)
Enfermedad de Hodgkin/genética , Linfoma Cutáneo de Células T/genética , Trastornos Linfoproliferativos/genética , Enfermedades de la Piel/genética , Linfocitos T/patología , Adulto , Secuencia de Bases , Células Clonales , Reordenamiento Génico , Enfermedad de Hodgkin/patología , Humanos , Linfoma Cutáneo de Células T/patología , Trastornos Linfoproliferativos/patología , Masculino , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Receptores de Antígenos de Linfocitos T alfa-beta/genética , Células de Reed-Sternberg/patología , Enfermedades de la Piel/patología
9.
Health Phys ; 57(1): 61-70, 1989 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-2745098

RESUMEN

The U.S. Bureau of Mines and the Mine Safety and Health Administration have evaluated, for accuracy and reliability, a commercially available Instant Working Level Meter (IWLM) used by the mining industry to measure short-lived 222Rn-progeny concentrations. Six evaluation parameters were determined experimentally. These included two alpha and two beta detector efficiencies for the short-lived 222Rn progeny and two internal conversion factors. The experimental procedure detailing the evaluation technique is described in the paper. The measuring accuracy of 13 instruments is as follows: average inherent uncertainty (at least 68% confidence interval) is +/- 18%; for counting statistics and rounding at 0.10 WL (2.1 microJ m-3), coefficients of variation range from +/- 15% at low gamma flux backgrounds to +/- 50% at gamma flux backgrounds of 0.39 microC kg-1 h-1 (1.5 mR h-1). All parameters were derived theoretically and measured experimentally. All tests were conducted at a sample flow rate of 2.5 L min-1. A sample air flow rate of 7.5 L min-1 can lower the counting statistics to more acceptable levels at 0.1 WL (2.1 microJ m-3).


Asunto(s)
Contaminantes Ocupacionales del Aire/análisis , Contaminantes Radiactivos del Aire/análisis , Contaminantes Atmosféricos/análisis , Minería , Radiometría/instrumentación , Radón/análisis , Bismuto/análisis , Exposición a Riesgos Ambientales , Estudios de Evaluación como Asunto , Radioisótopos de Plomo/análisis , Matemática , Polonio/análisis , Probabilidad , Radioisótopos/análisis , Conteo por Cintilación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...